​

biote Stock (NASDAQ:BTMD)

ForecastRevenueFinancialsChartTranscripts
biote by TradingView

Previous Close

$5.74

52W Range

$3.79 - $8.44

50D Avg

$6.13

200D Avg

$6.19

Market Cap

$308.63M

Avg Vol (3M)

$140.24K

Beta

0.94

Div Yield

-

BTMD Company Profile

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

194

IPO Date

Apr 28, 2021

Website

BTMD Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22
Service Revenue$2.79M$1.82M
Other Service Revenue$697.00K-
Dietary Supplements$38.09M$32.41M
Training Service Revenue$1.17M$973.00K
Product Revenue$182.57M$163.13M

Fiscal year ends in Dec 23 | Currency in USD

BTMD Financial Summary

Dec 23Dec 22Dec 21
Revenue$185.36M$164.96M$139.40M
Operating Income$28.66M$-60.72M$34.56M
Net Income$3.32M$1.32M$32.62M
EBITDA$9.23M$9.24M$35.98M
Basic EPS$0.13$0.16$-0.87
Diluted EPS$0.13$0.16$-0.87

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 13, 24 | 2:56 AM
Q2 24Aug 10, 24 | 2:42 PM
Q1 24May 07, 24 | 12:00 AM

Peer Comparison

TickerCompany
EHCEncompass Health Corporation
MODVModivCare Inc.
ACHCAcadia Healthcare Company, Inc.
AMEDAmedisys, Inc.
INNVInnovAge Holding Corp.
OPCHOption Care Health, Inc.
ENSGThe Ensign Group, Inc.
PNTGThe Pennant Group, Inc.